Targeting Chelatable Iron as a Therapeutic Modality in Parkinson's Disease

2013607 citationsJournal Articlehybrid Open Access

Authors

David Devos · Université de Lille

Caroline Moreau · Centre Hospitalier Universitaire de Lille

Jean Christophe Devedjian · Université Lille Nord de France

Jérôme Kluza · Inserm

Maud Pétrault · Université de Lille

Charlotte Laloux · Université de Lille

Aurélie Jonneaux ·

Abstract

The therapeutic features of a chelation modality established in translational models and in pilot clinical trials warrant comprehensive evaluation of symptomatic and/or disease-modifying potential of chelation in PD.

Topics & Keywords

Parkinson's Disease Mechanisms and Treatments Neurological diseases and metabolism Neurological disorders and treatments

UN Sustainable Development Goals

Industry, innovation and infrastructure

Publication Details

Published in: Antioxidants and Redox Signaling

Volume 21, Issue 2, pp. 195-210

DOI: 10.1089/ars.2013.5593

Field-Weighted Citation Impact: 18.40